Lobe Sciences CEO Touts Targeted Low Dosing for Better Patient Outcomes
Trip to Treatment: Lobe Sciences CEO Touts Targeted Low-dosing for Better Patient Outcomesyoutu.be Lobe Sciences (CSE:LOBE,OTCQB:LOBEF) is taking a different approach to psychedelic treatment by using low-dose, sub-psychedelic stimulation targeting…